Showing results (161-170 of 417) with videos related to
Sort By:
Pageof 42
Genes, Chromosomes & Cancer|April 1, 2006
A genome wide linkage search for breast cancer susceptibility genesPaula Smith, Lesley McGuffog, Douglas F Easton, et al.Endocrine-Related Cancer|October 2, 2013
Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction studyAnja Rudolph, Rebecca Hein, Sara Lindström, et al.Journal of the National Cancer Institute|November 25, 2024
Childhood, adolescent, and young adulthood cancer risk in BRCA1 or BRCA2 pathogenic variant carriersShuai Li, Laura Madanat-Harjuoja, Goska Leslie, et al.Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies|July 17, 2012
Genome-wide association study for ovarian cancer susceptibility using pooled DNAYi Lu, Xiaoqing Chen, Jonathan Beesley, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 19, 2011
Prostate cancer susceptibility polymorphism rs2660753 is not associated with invasive ovarian cancerErnest K Amankwah, Linda E Kelemen, Qinggang Wang, et al.BMC Medicine|July 4, 2015
Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosisMarcelo Sobral-Leite, Jelle Wesseling, Vincent T H B M Smit, et al.Nature|June 18, 2002
Mutations of the BRAF gene in human cancerHelen Davies, Graham R Bignell, Charles Cox, et al.Oncotarget|February 10, 2017
TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancerRainer Fagerholm, Sofia Khan, Marjanka K Schmidt, et al.Gynecologic Oncology|August 7, 2013
ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome AtlasSharon E Johnatty, Jonathan Beesley, Bo Gao, et al.The Journal of Pathology|July 15, 2015
Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significanceJodi M Saunus, Michael C J Quinn, Ann-Marie Patch, et al.Pageof 42